Mast Group Ltd. manufactures and supplies diagnostic, microbiology and immunology products. The company was founded in 1957 and is headquartered in Bootle, MR.

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

Cepheid Inc (NASDAQ: CPHD) is an American molecular diagnostics company that develops, manufactures and markets fully integrated systems for testing in the clinical market, and for application in its original non-clinical market. The company's systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. It was the winner of 2006 Industrial Design Excellence Awards for its product, Reagent Bead Dispenser. It won the federal contract by "MRSA Reagent Test Kits" in 2012. One of the company's customers is U.S. Food and Drug Administration (FDA). Danaher acquired Cepheid on November 4, 2016.

Hennepin Life Sciences is a growth stage human and animal health company that is uniquely focused on the development of patent protected, novel, naturally-derived anti-infective compounds for the prevention and treatment of a wide array of infections. We created innovative nature-based therapies by combining molecular concepts of infection to clinical applications.Founded in 2009 from a technology transfer out of the University of Minnesota, Hennepin Life Sciences (HLS) is a Phase2 clinical trial stage, Minnesota -based biotechnology firm that continues to develop a patented approach to address the global super bug challenge. Today, HLS continues to expand its product platform intellectual property, advance the practical science through clinical studies and is active forging distribution partnerships to initially reach clinical application.

Part of New Wave Co., Ltd., Eins Co., Ltd. is a South Korean company that operates theme parks. New Wave Co., Ltd. acquired Eins Co., Ltd. from T'way Holdings, Inc. on July 30, 2013 for $1.44 million.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Probiotical SpA manufactures probiotic lactic ferments. It offers probiotics, healthcare, food supplements, LBPs, pharma, synbiotics, medical devices, and clinical studies. The company was founded in 1985 and is headquartered in Novara, Italy.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus.

Operates as a clinical research company that develops treatments for infections

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Qingdao Haifen Marine Biotechnology Co., Ltd., established on 2010-08-31, Business scope includes research:synthetic detergent,Sales:Soap,cosmetic,Daily chemical products(Free of Hazardous Chemicals),oral hygiene products,hygiene products,daily necessities,Cleaning supplies,Cleaning service,Biotechnology Technology Services;Wholesale and retail of plastic products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Essenlix Corp. is a private company headquartered in Monmouth Junction, NJ, that develops instant mobile health self-test platform. The firm was founded in 2013 by Lin Chou and Stephen Y. Chou.\nThe company says this about itself: Essenlix Corporation, a five-year startup, is a premier digital health company ? a developer, manufacturer, and provider of mobile instant health test solutions for both personal and clinical use, providing the link between personal health, remote monitoring and treatment, and e-health services. Through its iMOSTTM platform, Essenlix is the world leader in providing accurate, reliable, and decentralized personal mobile health testing using a single drop of body fluid and a simple mobile-phone based handheld device in about 60 seconds, accessible anywhere, anytime, by anyone. Essenlix's iMOST platform was made possible by its invention of the Intelligent Fault Tolerant paradigm, QMAXTM universal All-In-One sample holder, intelligent nanostructures, nano-enabled AI/machine learning (NEAMTM) and integration with advanced biology. (Essenlix is pronounced Eh-Sen-Lix).

Guilin Liangming Agricultural Technology Development Co., Ltd., established on 2013-07-11, Business scope includes agricultural technology development,Agricultural sightseeing tourism service,farming,Forest,animal husbandry,poultry planting,Breeding and Sales;Processing of environmental protection bags,Sales;Catering Management,plan,Hypoglycemic,Expelling Wind Dietary Tea,Development and technical guidance of health-preserving diet for pregnant women and confinement,Housekeeping Service Management;Landscaping construction,maintain.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.

Shanghai Sine Pharmaceutical Co. Ltd., part of Shanghai Pharmaceuticals Holding Co., Ltd., is a company headquartered in Shanghai, China, that manufactures and distributes pharmaceutical products. On February 03, 2010 Shanghai Pharmaceuticals Holding Co., Ltd. acquired Shanghai Sine Pharmaceutical Co. Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd. for $124.70 million.